Search - tctmd.com

Displaying 221 - 240 of 277

Sort: Relevancy | Date

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

Presentation TCT 2013

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Presenter: Andr?s Kom?csi, Andr?s Vorobcsuk, D?niel Kehl, Daniel Aradi

January 31, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

Yael L. Maxwell

January 13, 2013

News Daily News

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Caitlin E. Cox

January 09, 2013

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Caitlin E. Cox

January 09, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Jason Kahn

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

Advertisement

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Genetic Alleles Affect Response to Prasugrel in ACS Patients

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content